These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20124894)

  • 41. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic alterations in liver cirrhosis.
    La Villa G; Gentilini P
    Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V; Fernandez J; Ginès P
    Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Natural course and physiopathology of ascites in the cirrhotic patient].
    Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
    Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
    Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac involvement in liver cirrhosis.
    Gatta A; Merkel C; Sacerdoti D; Angeli P
    Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoalbuminemia.
    Gatta A; Verardo A; Bolognesi M
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S193-9. PubMed ID: 23073857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Albumin infusion may deleteriously promote extracellular fluid overload without improving circulating hypovolemia in patients of advanced cirrhosis with diabetes mellitus and sepsis.
    Kumar R; Kumar S; Lata S
    Med Hypotheses; 2013 Apr; 80(4):452-5. PubMed ID: 23375411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis.
    Patch D; Burroughs A
    N Engl J Med; 1999 Dec; 341(23):1773-4. PubMed ID: 10610455
    [No Abstract]   [Full Text] [Related]  

  • 53. Decompensated Cirrhosis and Fluid Resuscitation.
    Maynard E
    Surg Clin North Am; 2017 Dec; 97(6):1419-1424. PubMed ID: 29132516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
    ;
    Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.
    Garcia-Martinez R; Caraceni P; Bernardi M; Gines P; Arroyo V; Jalan R
    Hepatology; 2013 Nov; 58(5):1836-46. PubMed ID: 23423799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding the mechanisms of paracentesis-induced crculatory dysfunction.
    Sola-Vera J; Such J
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):295-8. PubMed ID: 15195893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathophysiological basis of albumin use in cirrhosis.
    Arroyo V; Fernandez J
    Ann Hepatol; 2011 May; 10 Suppl 1():S6-14. PubMed ID: 21566249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of albumin infusion in cirrhosis-associated complications.
    Heybe MA; Mehta KJ
    Clin Exp Med; 2024 Mar; 24(1):58. PubMed ID: 38551716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of albumin : State of the art].
    Mayerhöfer T; Wiedermann CJ; Joannidis M
    Med Klin Intensivmed Notfmed; 2021 Nov; 116(8):655-664. PubMed ID: 34618163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [When should we give albumin in patients with cirrhosis?].
    Bochatay L; Elkrief L; Spahr L
    Rev Med Suisse; 2015 Sep; 11(484):1596, 1598-601. PubMed ID: 26502620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.